Skip to main content
Equibles
BDPT logo

BDPT · Bioadaptives, Inc. · Metrics

Track BDPT — free

Use BDPT with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research BDPT.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.00 0.00 (-5.56%) At close · Oct 19
Rebalance outlook locked
Going-concern doubt — flagged Aug 19, 2026

Substantial doubt about the company's ability to continue as a going concern.

“The ability to successfully resolve these factors raises substantial doubt about the Company's ability to continue as a going concern.”
View the 10-Q filed Aug 19, 2026
Market Cap
$334,775
Shares
196.93M
Volume · Oct 19 20.88M Avg daily vol (3M) 25.47M

BDPT metrics

50 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.00
Market cap
$334,775

Price action

20 metrics
Price change (1W)
+20.0%
Price change (30D)
-10.0%
Price change (3M)
+12.5%
Price change (6M)
-88.0%
Price change (YTD)
-91.9%
Price change (1Y)
-93.5%
Trailing year
Price change (5Y)
—
52-week high
$0.05
52-week low
$0.00
Change from 52-week high
-96.5%
Change from 52-week low
+100.0%
Annualized volatility
453.1%
Annualized volatility (3M)
391.0%
Beta
2.9
RSI (14D)
47.3
Price vs SMA 50
-4.6%
Price vs SMA 200
-87.9%
Avg volume (3M)
25.55M
Relative volume
0.1
Average dollar volume
$57,594

Company

3 metrics
Sector
Consumer Defensive
Industry
Packaged Foods
Shares outstanding
196.93M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
13.9×
reciprocal yield 7.2%
P / book
—
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-328.3%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
77.4%
Operating margin
-3,557.0%
Trailing 12 months
Net margin
-4,553.2%
Gross profit (TTM)
$19,787
Operating profit (TTM)
−$909,200
Net income (TTM)
−$1.16M
Trailing 12 months
Diluted EPS (TTM)
$-0.12
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$-0.18

Growth

11 metrics
Revenue growth YoY
+55.0%
Year over year
Net income growth YoY
—
Revenue (TTM)
$25,561
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+2,849.6%
Year over year · more shares
Revenue CAGR (3Y)
+2.1%
Revenue CAGR (5Y)
+2.3%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
—
Return on assets
-1,477.6%
Debt / equity
—
Current ratio
0.0
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
0.0
Interest coverage
-3.6
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$29,221
Latest balance sheet
Cash & equivalents
$29,221
Total assets
$78,767
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$436,361
Capital expenditures (TTM)
$0
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
—
13F filer change QoQ
—
Institutional ownership
—
Conviction holders (share of 13F filers)
—
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
—
Holder tenure
—
Price vs estimated holder cost
—

Ownership (registered funds)

1 metrics
Index-fund ownership
0.0%

Short interest

3 metrics
Short interest
—
Latest settlement
Days to cover
—
Short-squeeze score
—

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
Flagged
Key facts CIK 1575142